Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden

被引:55
|
作者
Ufer, M [1 ]
Kimland, E
Bergman, U
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Clin Pharmacol, SE-14186 Stockholm, Sweden
[2] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany
[3] Stockholm Cty Council, Pharmacoepidemiol Ctr, LAKSAK, Stockholm, Sweden
[4] Huddinge Univ Hosp, Med Prod Agcy, Reg Adverse Drug React Ctr, Stockholm, Sweden
关键词
off-label; children; drug prescribing; paediatric; outpatient; adverse drug reaction;
D O I
10.1002/pds.858
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To investigate the extent and characteristics of off-label prescribing for paediatric outpatients among drugs reported to have caused an adverse reaction. Methods A retrospective, cross-sectional, observational analysis of spontaneous adverse drug reaction (ADR) reports in Sweden in the year 2000. We included all reports concerning drugs prescribed for outpatients younger than 16 years. Each ADR was classified with respect to its causality, seriousness and type of reaction. Off-label prescribing was evaluated with respect to age, dose, indication, formulation and route and frequency of administration. Results We identified 112 patient-linked reports corresponding to 158 ADRs of which 31% were serious. Antiasthmatic drugs were most frequently suspected as a cause of almost every third adverse reaction. The average proportion of off-label drug prescribing amounted to 42.4%. It was more frequently associated with serious than non-serious ADRs and mostly due to a non-approved age or dose. The most common clinical manifestations were psychiatric disorders and mucocutaneous inflammatory reactions. Conclusions Off-label prescribing for paediatric outpatients is common among drugs reported to have caused an ADR. It is suggested to further identify unlabelled drugs frequently contributing to, in particular serious ADRs in children for a proper benefit-fisk assessment of off-label drug use. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [31] Relationship Between Adverse Drug Reactions and Unlicensed/Off-label Drug Use in Hospitalized Children (EREMI)
    Mimouni, Y.
    Nguyen, K. A.
    Paret, N.
    Herve, M.
    Bossard, N.
    Roche, L.
    Remontet, L.
    Kassai, B.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 77 - 77
  • [32] Off-label Drug Prescription Pattern and Related Adverse Drug Reactions in the Medical Intensive Care Unit
    Raut, Asawari
    Krishna, Kavita
    Adake, Utkarsha
    Sharma, Apurva A.
    Thomas, Anitta
    Shah, Jignesh
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (08) : 873 - 878
  • [33] Paediatric adverse drug reactions: Data from an Italian interregional database of spontaneous reports
    Salvo, F.
    Cutroneo, P. M.
    Polimeni, G.
    Moretti, U.
    Caputi, A. P.
    [J]. DRUG SAFETY, 2007, 30 (10) : 969 - 969
  • [34] Paediatric adverse drug reactions: a review of spontaneous reports registered by a Regional PharmacoVigilance Center
    Foucras, G.
    Rousseau, V.
    Chebane, L.
    Maupiler, M.
    Durrieu, G.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 24 - 24
  • [35] Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia
    Landwehr, Caitlin
    Richardson, Jennifer
    Bint, Lewis
    Parsons, Richard
    Sunderland, Bruce
    Czarniak, Petra
    [J]. PLOS ONE, 2019, 14 (01):
  • [36] Off-label drug use and Adverse Drug Events (ADEs) in paediatric patients: An analysis of the Jordanian National Pharmacovigilance Database
    Al-zubiedi, S.
    Bawaresh, N.
    [J]. DRUG SAFETY, 2017, 40 (10) : 989 - 990
  • [37] Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature
    Mason, Jennifer
    Pirmohamed, Munir
    Nunn, Tony
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (01) : 21 - 28
  • [38] Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature
    Jennifer Mason
    Munir Pirmohamed
    Tony Nunn
    [J]. European Journal of Clinical Pharmacology, 2012, 68 : 21 - 28
  • [39] Off-label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study
    Pratico, Andrea D.
    Longo, Laura
    Mansueto, Silvana
    Gozzo, Lucia
    Barberi, Ignazio
    Tiralongo, Venera
    Salvo, Vincenzo
    Falsaperla, Raffaele
    Vitaliti, Giovanna
    La Rosa, Mario
    Leonardi, Salvatore
    Rotondo, Antonio
    Avola, Nicoletta
    Sgarlata, Debora
    Damiano, Annalisa
    Tirantello, Massimo
    Anzelmo, Gaspare
    Cipolla, Domenico
    Rizzo, Angelo
    Russo, Antonio
    Ruggieri, Martino
    Salomone, Salvatore
    Drago, Filippo
    [J]. CURRENT DRUG SAFETY, 2018, 13 (03) : 200 - 207
  • [40] Assessment of Adverse Drug Reactions to Off-Label Drug Use in an Oncological Population Treated in a Northern Italian Hospital
    Piccoli, L.
    Cazzador, F.
    Coppola, M.
    Berti, E.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1256 - 1256